Skip to main content
Clinical Trials/NCT01638143
NCT01638143CompletedNot Applicable

Comparison of Bioavailability of Three Different Vitamin K2 Formulations

Maastricht University Medical Center1 site in 1 country24 target enrollmentStarted: November 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
24
Locations
1
Primary Endpoint
MK-7 absorption profiles

Study Overview

Brief Summary

The primary objective of this study is to compare absorption of vitamin K2 (menaquinone-7) after intake of three different vitamin K2 supplements.

Detailed Description

Several manufacturers are producing vitamin K2 raw material in different forms, namely oil and powder. To ensure bioequivalence of different vitamin K2 sources, the investigators are interested to compare the bioavailability of three different vitamin K2 formulations that are already commercially available. Two different oils and one powder product will be compared in this randomized cross-over trial. The investigators hypothesize that different vitamin K2 sources give no differences in bioavailability of vitamin K2.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
20 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy men and women, aged between 20 and 40 years
  • Normal body weight and height (18.5 kg/m2 < BMI < 30 kg/m2)
  • Stable body weight (weight gain or loss < 3 kg in past 3 mo)
  • Written consent to take part in the study
  • Agreement to adhere to dietary restrictions required by the protocol

Exclusion Criteria

  • Abuse of drugs and/or alcohol
  • Use of vitamin supplements containing vitamin K
  • Soy allergy
  • Pregnancy
  • a history of) metabolic or gastrointestinal diseases including hepatic disorders
  • Chronic degenerative and/or inflammatory diseases, e.g. diabetes mellitus, renal failure
  • Use of oral anticoagulants
  • Corticoid treatment
  • Subjects with anaemia or subjects who recently donated blood or plasma
  • Systemic treatment or topical treatment likely to interfere with coagulation metabolism (salicylates, antibiotics)

Outcomes

Primary Outcomes

MK-7 absorption profiles

Time Frame: 9 weeks

The purpose of this study is to compare the MK-7 absorption profiles after intake of three different vitamin K2 (MK-7) products that are already on the market. The main study parameter is therefore the calculated AUC value from the individual MK-7 absorption profiles.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Bio-equivalence Study | Clinical Trial